K
Kadimastem Ltd
TASE:KDST
Kadimastem Ltd
TASE:KDST
Price:
2 794
ILS
-1.13%
Market Closed
Market Cap:
₪117.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Kadimastem Ltd
TASE:KDST
|
IL |
Balance Sheet
Balance Sheet Decomposition
Kadimastem Ltd
Kadimastem Ltd
Balance Sheet Decomposition is not available for
Kadimastem Ltd
Kadimastem Ltd
Balance Sheet
Kadimastem Ltd
Kadimastem Ltd
Currency: ILS
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
2
|
1
|
10
|
11
|
0
|
5
|
23
|
6
|
4
|
2
|
|
| Cash |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
2
|
1
|
10
|
11
|
0
|
5
|
23
|
6
|
4
|
2
|
|
| Short-Term Investments |
0
|
7
|
5
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
2
|
1
|
1
|
2
|
1
|
1
|
2
|
1
|
1
|
1
|
2
|
0
|
|
| Accounts Receivables |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
9
|
9
|
6
|
3
|
10
|
12
|
2
|
7
|
24
|
7
|
6
|
3
|
|
| PP&E Net |
3
|
3
|
2
|
2
|
2
|
1
|
1
|
5
|
3
|
3
|
4
|
2
|
0
|
|
| PP&E Gross |
3
|
3
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
1
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Total Assets |
4
N/A
|
12
+187%
|
12
-3%
|
8
-34%
|
5
-40%
|
12
+155%
|
15
+20%
|
7
-50%
|
11
+48%
|
27
+153%
|
12
-54%
|
8
-33%
|
3
-61%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
3
|
1
|
2
|
3
|
6
|
5
|
5
|
7
|
4
|
3
|
4
|
2
|
2
|
|
| Accrued Liabilities |
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
3
|
1
|
4
|
2
|
2
|
1
|
0
|
6
|
11
|
4
|
4
|
4
|
4
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
24
|
|
| Other Current Liabilities |
0
|
0
|
1
|
3
|
2
|
2
|
3
|
3
|
2
|
2
|
1
|
1
|
2
|
|
| Total Current Liabilities |
7
|
4
|
9
|
8
|
10
|
7
|
7
|
17
|
17
|
11
|
11
|
8
|
32
|
|
| Long-Term Debt |
1
|
1
|
0
|
0
|
2
|
0
|
0
|
2
|
1
|
0
|
2
|
1
|
0
|
|
| Other Liabilities |
3
|
0
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
4
|
0
|
|
| Total Liabilities |
11
N/A
|
5
-54%
|
10
+104%
|
9
-15%
|
13
+49%
|
8
-41%
|
8
+0%
|
19
+145%
|
19
-2%
|
12
-37%
|
12
+2%
|
13
+5%
|
32
+155%
|
|
| Equity | ||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
4
|
4
|
4
|
|
| Retained Earnings |
26
|
32
|
43
|
58
|
75
|
92
|
114
|
144
|
168
|
187
|
208
|
227
|
253
|
|
| Additional Paid In Capital |
19
|
39
|
44
|
57
|
66
|
96
|
120
|
131
|
158
|
199
|
205
|
219
|
220
|
|
| Total Equity |
7
N/A
|
7
N/A
|
2
-79%
|
1
N/A
|
9
-736%
|
4
N/A
|
7
+57%
|
12
N/A
|
8
+33%
|
15
N/A
|
0
-98%
|
4
N/A
|
29
-568%
|
|
| Total Liabilities & Equity |
4
N/A
|
12
+187%
|
12
-3%
|
8
-34%
|
5
-40%
|
12
+155%
|
15
+20%
|
7
-50%
|
11
+48%
|
27
+153%
|
12
-54%
|
8
-33%
|
3
-61%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
11
|
16
|
18
|
2
|
2
|
6
|
10
|
11
|
20
|
34
|
36
|
4
|
4
|
|
Switch to:
Switch to:
See Also
Discover More
